Board-certified pediatrician and gene therapy expert with extensive experience leading the development of novel biotechnologies for CNS disorders. Specialized in AAV gene therapy and hematopoietic stem cell applications, her work provided the scientific basis for the first approved therapy for X-linked Adrenoleukodystrophy. A recognized global authority in cell and gene therapy, she has held senior leadership roles across academia and the
biopharmaceutical industry.

Prior experience includes: SVP and Scientific Chair at AskBio; Founder of BrainVectis; Research Director at INSERM and Professor at University Paris Descartes; Past President of the ESGCT; Awarded the Outstanding Achievement Award by the European Society for Cell & Gene Therapy.